---
category: news
title: "Lantern Pharma Announces Launch of Antibody Drug Conjugate (ADC) Program to Target Solid Tumors & Blood Cancers through Agreement with Califia Pharma"
excerpt: "PRNewswire/ -- Lantern Pharma (Nasdaq: LTRN), a clinical-stage biopharma company using its proprietary RADR Â® artificial intelligence (\"A.I.\") platform to transform cancer drug development and identify patients who will benefit from its targeted oncology therapeutics,"
publishedDateTime: 2021-01-04T12:30:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/lantern-pharma-announces-launch-of-antibody-drug-conjugate-adc-program-to-target-solid-tumors-blood-cancers-through-agreement-with-califia-pharma-1029930022"
webUrl: "https://markets.businessinsider.com/news/stocks/lantern-pharma-announces-launch-of-antibody-drug-conjugate-adc-program-to-target-solid-tumors-blood-cancers-through-agreement-with-califia-pharma-1029930022"
type: article

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://smartableai.github.io/artificial-intelligence/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://mma.prnewswire.com/media/1216507/Lantern_Pharma_Logo.jpg"
    width: 400
    height: 296
    isCached: true

secured: "4EX+oUhIwR3YdOUIyjYpgme6oaDcsDBHv0LAVzBccy8te2XHjEvQ+KC2+ID193SXv5jy7bkGFB9KUB0ZuMtuAoib5xh1cISOYBKlrHEgM8YUtR28Ca0D7q47Z3vivyOSr8o/tz5t+qi4zh96dgaAO/B9k48M4NTxfXxD1BwTTTC0m9Bm7UJayMPXOXCMO6dIC9VelrjDxGfB2aYFXJeTL4kupNGW/OtGlpQD+mxEKRdwtDtuDzPbdHFQppMtSfcYB+SLCrqWAtG0O3gyhofyqYW7C7GUNZVUz4uxt3Xtq/X7sV3XEsh07jht5SEF+GsNkCZzwWj+AKfIvjjlzM09G/rtqzhQzJHLGta9I04Gu30=;qog79UEYL0gFbUxz6Cux2A=="
---

